[Guillain-Barré syndrome].
Koga
M
M
Department of Neurology, Yamaguchi University School of Medicine.
Yuki
N
N
D001323:Autoantibodies / Q000097:blood; D015415:Biomarkers / Q000097:blood; D016123:Campylobacter jejuni / Q000276:immunology; D003587:Cytomegalovirus / Q000276:immunology; D005677:G(M1) Ganglioside / Q000276:immunology; D005732:Gangliosides / Q000276:immunology; D020275:Guillain-Barre Syndrome / Q000145:classification / Q000175:diagnosis; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D010951:Plasma Exchange; D011379:Prognosis
D001323:Autoantibodies; D015415:Biomarkers; D005732:Gangliosides; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous; D005677:G(M1) Ganglioside; C039129:GQ1b ganglioside